Terapin
PrivateLast Round
Private Equity
Aug 1, 2022
Est. Valuation
$58.62M
Total Funding Raised
$167.66M
Company Overview
Terapin operates in Media, Entertainment & Gaming and is based in Seoul. Its latest recorded funding round was a Private Equity round in August 2022.
Terapin is a digital content company that specializes in the production, distribution, and monetization of webtoons, web novels, and character intellectual property.
Sector
Media, Entertainment & Gaming
Verticals
Content Creation, Digital Publishing, Streaming Platforms, Gaming, Creator Economy
Business Model
B2C
Customer Profile
Subscription SaaS, Revenue Share, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Terapin Comparables
Compare Terapin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TOPCO CO., LTD. | 82% | |
| SK Telecom | 79% | |
| Kakao Corp. | 78% |
For institutional investors. Book with your work email.
Terapin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Aug 1, 2022 | ||||
| Private Equity | Jan 14, 2022 | ||||
| VC Round | Sep 14, 2021 | ||||
| Series B | Apr 21, 2021 | ||||
| Series A Extension | Jun 21, 2020 | ||||
Series A | Nov 13, 2019 |
For institutional investors. Book with your work email.
Terapin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DA Value Investment | Series A Extension, Series A |
| Hyundai Investment Partners | Series B, Series A Extension, Series A |
| KB Investment | Series B, Series A Extension, Series A |
| Wonik Investment Partners | Series B, Series A Extension |
| Affirma Capital | Private Equity |
| NPX Capital | Private Equity, VC Round |
| Daekyo Investment | Series B, Series A Extension, Series A, Private Equity |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2022
$93M round with Affirma Capital and NPX Capital.
- Jan 14, 2022
$55M round led by NPX Capital.
For institutional investors. Book with your work email.
Terapin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Terapin's valuation, stock price, and market status.
Is Terapin a public or private company?
Terapin is a private company.
What is the current stock price of Terapin?
Terapin is a private company, so its shares have no public market price. Caplight tracks Terapin's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Terapin worth (valuation)?
Terapin's valuation is estimated at $58.6M based on funding round data.
Can I buy Terapin stock?
Terapin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Terapin's last funding round?
Terapin's most recent funding round was Private Equity on August 1, 2022.
Who are the main investors in Terapin?
Key investors in Terapin include NPX Capital.
Will Terapin IPO soon?
No public IPO plans have been announced for Terapin.
How can I track Terapin secondary market activity?
Caplight tracks bids, offers, and trades in Terapin's shares on secondary markets.